(Q37307724)

19 August 2017

1 reference

title

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review (English)

1 reference

19 August 2017

1 reference

Ginna G Laport

1

1 reference

19 August 2017

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

49

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

1854-1859

1 reference

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Early interim PET scan in Hodgkin lymphoma: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802304974

10.1080/10428190802304974

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference